Comparing the mutation carriers in genes besides BRCA1/2 in the OV cohort and carriers in the BROV cohort, there was no significant difference in the age of diagnosis, histology, and cancer stage and grade (data not shown). The gene discussed is BRCA1; the disease is cancer.